J&J to buy Intra-Cellular Therapies for $14.6B, picking up mental health drug The deal includes Caplyta, a medicine that could soon be approved in larger indications

https://www.statnews.com/2025/01/13/jnj-intracellular-caplyta-mental-health-neuroscience-acquisition/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz-_1chfIyqFtqEK3BjFJohXjwzDT8n_euXbqVhX7X6rVMKlArqrAor0moeuFlWizcHhFIgQcSIDdRWf-NWDKC4KsEeOTQw&_hsmi=342313978&utm_content=342313978&utm_source=hs_email